Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 30 citing articles:

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Frank L.J. Visseren, François Mach, Yvo M. Smulders, et al.
European Heart Journal (2021) Vol. 42, Iss. 34, pp. 3227-3337
Open Access | Times Cited: 4289
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Frank L.J. Visseren, François Mach, Yvo M. Smulders, et al.
European Journal of Preventive Cardiology (2021) Vol. 29, Iss. 1, pp. 5-115
Open Access | Times Cited: 378
Exposure to a mixture of legacy, alternative, and replacement per- and polyfluoroalkyl substances (PFAS) results in sex-dependent modulation of cholesterol metabolism and liver injury
Katherine Roth, Zhao Yang, Manisha Agarwal, et al.
Environment International (2021) Vol. 157, pp. 106843-106843
Open Access | Times Cited: 201
Gender medicine: effects of sex and gender on cardiovascular disease manifestation and outcomes
Vera Regitz‐Zagrosek, Cathérine Gebhard
Nature Reviews Cardiology (2022) Vol. 20, Iss. 4, pp. 236-247
Open Access | Times Cited: 151
Guía ESC 2021 sobre la prevención de la enfermedad cardiovascular en la práctica clínica
Frank L.J. Visseren, François Mach, Yvo M. Smulders, et al.
Revista Española de Cardiología (2022) Vol. 75, Iss. 5, pp. 429.e1-429.e104
Closed Access | Times Cited: 47
Gender Bias in Diagnosis, Prevention, and Treatment of Cardiovascular Diseases: A Systematic Review
Abdullah Al Hamid, Rachel Beckett, Megan Wilson, et al.
Cureus (2024)
Open Access | Times Cited: 11
Gender inequalities in secondary prevention of cardiovascular disease: a scoping review
Irene López Ferreruela, B. Obón Azuara, Sara Malo, et al.
International Journal for Equity in Health (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Sex differences in LDL-C control in a primary care population: The PORTRAIT-DYS study
Cristina Gavina, Francisco Araújo, Carla Teixeira, et al.
Atherosclerosis (2023) Vol. 384, pp. 117148-117148
Open Access | Times Cited: 15
Sex differences in major adverse cardiovascular and cerebrovascular event risk among central retinal artery occlusion patients
Ting Chen, Yuedan Wang, Xuejie Li, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Sex Differences in Therapies against Myocardial Ischemia-Reperfusion Injury: From Basic Science to Clinical Perspectives
Lejla Medzikovic, Tara Azem, Wasila Sun, et al.
Cells (2023) Vol. 12, Iss. 16, pp. 2077-2077
Open Access | Times Cited: 13
Gender inequalities in prescribing and initiation patterns of guideline-recommended drugs after acute myocardial infarction
Irene López-Ferreruela, Sara Malo, B. Obón Azuara, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
Cardiovascular Health in Women
Aury V. Garcia, Yorgos Strangas
Primary Care Clinics in Office Practice (2025)
Closed Access
Serum zinc levels are associated with obesity and low-density lipoprotein cholesterol in Mexican adults
Héctor Hernández‐Mendoza, Israel Martínez-Navarro, Edduin Hernández-Ochoa, et al.
Journal of Trace Elements in Medicine and Biology (2022) Vol. 73, pp. 127002-127002
Closed Access | Times Cited: 17
LDL-cholesterol target levels achievement in high-risk patients: An (un)expected gender bias
Martina Berteotti, Francesco Profili, Besmir Nreu, et al.
Nutrition Metabolism and Cardiovascular Diseases (2023) Vol. 34, Iss. 1, pp. 145-152
Open Access | Times Cited: 10
Sex aspects in lipoprotein metabolism, dyslipidemia, and lipid-lowering therapy: A comprehensive review
Jakub Michał Zimodro, M Mucha, Heiner K. Berthold, et al.
(2024)
Open Access | Times Cited: 2
Lipoprotein Metabolism, Dyslipidemia, and Lipid-Lowering Therapy in Women: A Comprehensive Review
Jakub Michał Zimodro, M Mucha, Heiner K. Berthold, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 913-913
Open Access | Times Cited: 2
Monoclonal Anti-PCSK9 Antibodies: Real-World Data
Giulia Guidotti, Viola Liberati, A. Sorrentino, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 15, pp. 4543-4543
Open Access | Times Cited: 2
Prescription Rates, Polypharmacy and Prescriber Variability in Swiss General Practice—A Cross-Sectional Database Study
Yael Rachamin, Levy Jäger, Rahel Meier, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 8
Sex Differences in the Primary Prevention of Cardiovascular Diseases in a Dutch Primary Care Setting
Pauline Kiss, Alicia Uijl, Estefania Betancur, et al.
Global Heart (2024) Vol. 19, Iss. 1, pp. 6-6
Open Access | Times Cited: 1
Use of statins and other lipid-modifying agents across pregnancy: A nationwide drug utilization study in Norway in 2005–2018
Jacob J. Christensen, Martin P. Bogsrud, Kirsten B. Holven, et al.
Atherosclerosis (2022) Vol. 368, pp. 25-34
Open Access | Times Cited: 5
Low-Density Lipoprotein Cholesterol Levels in Coronary Artery Disease Patients: Opportunities for Improvement
Gary J. Martin, Meron Teklu, Edwin Mandieka, et al.
Cardiology Research and Practice (2022) Vol. 2022, pp. 1-7
Open Access | Times Cited: 4
Misperceptions and management of risk: Ongoing challenges in women's cardiovascular health
Zareen Farukhi, Samia Mora
Atherosclerosis (2021) Vol. 324, pp. 109-111
Closed Access | Times Cited: 4
Bridging the gap: understanding sex differences in low-density lipoprotein cholesterol control through the lens of integrated data analysis and behavioural sciences
M. Julia Machline-Carrion
Heart (2024) Vol. 110, Iss. 15, pp. 972-973
Closed Access
Sex Disparities in the Management of Acute Coronary Syndromes: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program
Michael Sola, Elise Mesenbring, Thomas J. Glorioso, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 17
Open Access
Metabolic risk factor targets in relation to clinical characteristics and comorbidities among individuals with type 2 diabetes treated in primary care – The countrywide cross‐sectional AUSTRO‐PROFIT study
Harald Sourij, Kehkishan Azhar, Faisal Aziz, et al.
Diabetes Obesity and Metabolism (2024)
Open Access
Page 1 - Next Page

Scroll to top